期刊文献+

塞来昔布对糖尿病大鼠视网膜血管内皮生长因子表达的影响 被引量:4

Effect of celecoxib on the expression of vascular endothelial growth factors in diabetic rats
原文传递
导出
摘要 目的:观察塞来昔布对糖尿病大鼠视网膜血管内皮生长因子(VEGF)表达的影响。方法:将36只大鼠用链脲佐菌素(STZ)腹腔注射制成糖尿病大鼠模型,随机分成糖尿病组(n=18)和塞来昔布灌胃组(n=18)。塞来昔布灌胃组大鼠经口灌胃塞来昔布50mg/kg;糖尿病组经口灌胃等体积生理盐水。另18只正常大鼠为正常对照组。3个月后处死全部大鼠,应用免疫组织化学技术检测视网膜VEGF蛋白表达,逆转录-多聚酶链式反应(RT-PCR)方法检测视网膜VEGFmRNA和环氧化酶(COX)-2m RNA的表达。结果:正常对照组视网膜VEGFmRNA和COX-2mRNA表达量少,VEGF免疫组织化学反应弱阳性,VEGF蛋白表达量低;糖尿病组较正常对照组视网膜VEGFmRNA和COX-2mRNA表达均上调(P〈0.05),VEGF免疫组织化学反应呈强阳性,VEGF蛋白表达增高(P〈0.01);塞来昔布灌胃组较糖尿病组视网膜VEGFmRNA表达显著下降(P〈0.05),COX-2mRNA的表达无显著降低(P〉0.05),VEGF免疫组织化学反应阳性减弱,VEGF蛋白表达降低(P〈0.01)。结论:塞来昔布可通过抑制COX-2的活性进一步抑制STZ诱导的糖尿病大鼠视网膜VEGFmRNA及蛋白表达。 Objective To observe the effect of celecoxib on the expression vascular endothelial growth factors (VEGF) in diabetic rats. Methods Thirty-six wistar rats were used to establish the diabetic models by intraperitoneal injection with streptozotocin. The diabetic rats were divided into 2 groups: diabetic group (n=18) and celecoxib group (n= 18). Celecoxib (50 mg/kg) was administered orally to the rats in celecoxib group and the physiological saline with the same volume was given orally to the rats in diabetic group. Eighteen else rats were in normal control group. All of the rats were executed 3 months later. The expression of VEGF protein was detected by immunohistochemistry method. Reverse transcription-polymerase chain reaction(RT-PCR) analysis was used to examine the expression of retinal VEGF mRNA and cyclooxygenase-2 mRNA. Results Lower positive expression of VEGF mRNA and cyclooxygenase-2 mRNA, weakly positive action of immunohistochemistry of VEGF, and lower expression of VEGF protein were detected in normal control group; in the diabetic group, the expression of VEGF mRNA and cyclooxygenase-2 mRNA increased obviously comparing with which in the control group (P〈 0. 05), and the strongly positive action of immunohistochemistry of VEGF and increased expression of VEGF protein were detected (P〈0. 01); in celecoxib group, the expression of VEGF mRNA was lower than that in the diabetic group (P〈0. 05), the expression of cyclooxygenase-2 mRNA didn't decrease much (P〉0.05), the positive action of immunohistochemistry of VEGF decreased, and the expression of VEGF protein decreased (P 〈 0. 01 ). Conclusion By inhibiting the activation of cyclooxygenase-2, celecoxib can inhibit the expression of retinal VEGF mRNA and protein in diabetic rats induced by streptozotocin.
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2007年第4期265-268,共4页 Chinese Journal of Ocular Fundus Diseases
基金 吉林省科技发展计划资助项目(20050111)
关键词 糖尿病视网膜病变/病因学 糖尿病视网膜病变/病理生理学 血管内皮生长因子 类/分析 环氧化酶2抑制剂/治疗应用 Dabetic retinopathy/etiology Dabetic retinopathy/pathophysiology Vascular endothelial growth factors/analysis Cyclooxygenase 2 inhibitors/therapeutic use
  • 相关文献

参考文献13

  • 1Sone H, Okuda Y, KawakamiY, et al. Effects of high glucose concentration and a thromhoxane synthase inhibitor on the production of thromboxane A2 and prostaglandin I2 and E2 by retinal endothelial cells. Life Sci, 1996, 58: 239-243.
  • 2Cheng T. Cao W. Wen R. et al. Prostaglartdin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells. Invest Ophthalmol Vis Sci, 1998, 39:581-591.
  • 3Gonzalez E, Jawerbaum A, Sinner D, et al. Evolution of streptozotocin-pancreatic damage in the rat : modulatory effect of endothelins on the nitridergic and prostanoid pathway. Nitric Oxide, 1999, 3: 459-466.
  • 4Sone H, Okuda Y, Kawakami Y, et al. Effects of high glucose concentration and a thromboxane synthase inhibitor on the production of thromboxane A2 and prostaglandin I2 and E2 by retinal endothelial cells. Life Sci, 1996, 58: 239-243.
  • 5Cheng T, Cao W, Wen R, et al. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells. Invest Ophthalmol Vis Sci, 1998, 39:581-591.
  • 6Kern TS, Engerman RL. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes, 2001,50: 1636-1642.
  • 7Johnson EI, Dunlop ME, Larkins RG. Increased vasodilatory prostaglandin production in the diabetic rat retinal vasculature. Curr Eye Res, 1999, 18: 79-82.
  • 8Kompella UB, Lee VHL. Barriers to drug transport in ocular epithelia//Amidon GL, Lee PI, Topp EM. Transport Processes in Pharmaceutical Systems. New York: Marcel Dekker, 1999: 317-376.
  • 9Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med, 1994. 331:1480-1487.
  • 10Aukunuru JV, Sunkara G, Ayalasomayajula SP, et al. Evolution of streptozotocin-pancreatic damage in the rat: modulatory effect of endothelins on the nitridergic and prostanoid pathway. Nitric Oxide, 1999, 3:459-466.

同被引文献66

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部